New Insights into mRNA Vaccines and Cancer Risk

There’s been a significant discussion around the potential impacts of mRNA vaccinations on cancer risks, and a recent comprehensive review has presented some startling findings.

Details from the Review

A recent article highlighted a comprehensive review led by Nicholas Halsher, associated with Dr. Peter McCullough, which examined over 100 studies. The study claims that mRNA vaccines might actually lead to cancer through various mechanisms. The full review can be found in this source.

Overview of Key Findings

The review, titled “Comprehensive Literature Review by Mathilde Debaud,” indicates that mRNA COVID-19 vaccines could induce cancer through 17 different pathways. This analysis, highlighted in Le Point Critique, sheds light on the biological processes through which these injections may initiate or worsen malignant conditions.

Mechanisms Identified

• Genome Instability: The potential for mRNA to integrate into host DNA can cause mutations.
• Immune Escape: Spike proteins may inhibit important tumor suppressor genes, allowing cancer cells to evade the immune system.
• Failure of DNA Repair: Spike proteins can interfere with DNA repair processes, increasing mutation risks.
• Chronic Inflammation: Components of the vaccines can lead to lasting inflammation, known to promote cancer.
• Dysregulation of the Immune System: The suppression of T-cells can hinder cancer detection.
• Destruction of RNA: Changes in RNA can disrupt cell growth regulation.
• Activation of Carcinogenic Pathways: Certain signaling pathways may be activated, fostering tumor growth.
• Reactivation of Dormant Cancers: Previous remission may be compromised due to vaccination-induced inflammation.
• Impact of Multiple Injections: Repeated vaccinations might compromise immune response and support cancer resilience.
• Resistance to Treatment: Exposure to spike proteins can enable cancer cells to survive longer during therapies.

Exploring Alternative Treatments

Recognizing cancer’s commercial significance, Dr. Peter McCullough is investigating the low-cost drug Ivermectin as a potential cancer treatment. Initial studies indicate it could have promising applications.

A systematic review published in the journal Acta Poloniae Pharmaceutica suggests that Ivermectin is safe for cancer patients and may act through various anticancer mechanisms. There’s a call for well-structured clinical trials to fully explore its potential in oncology.

Combination Therapy Potential

Interestingly, combining Ivermectin with mebendazole might enhance its effectiveness against different cancers. Mebendazole has a long history as a medication used to eliminate parasites but may have implications for cancer treatment as well.

Quality and Trust in Treatments

Healthcare professionals have emphasized the need for reliable medicines from trustworthy sources. There’s a notable gap between business interests of large pharmaceutical companies and the need for affordable treatments.

The Wellness Company has recognized this gap, advocating for patient welfare over profits and offering innovative solutions in the healthcare space.

Reflections from Users

Testimonials have emerged from users sharing their positive experiences with Ivermectin and mebendazole. Many express gratitude for the hope and healing they received through these treatments.

While the information shared here is noteworthy, it should be considered informational and not a substitute for professional medical guidance.